warnings
Warnings: Status asthmaticus is a medical emergency. Excessive doses may be expected to be toxic.
FDA label a33a31a4-ee79-41c6-ac4d-fef66adfa81e
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- SPL set ID
- e8f79d62-6a62-4099-a282-1d33e9c2ea1b
- SPL ID
- a33a31a4-ee79-41c6-ac4d-fef66adfa81e
- Version
- 1
- Effective date
- 2010-04-23
- Source export date
- 2026-10-12
- Source partition
- 12
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-12/edd23646015c9adc800cdbe2b778398a2d2b70e90dce5721ef2b191499a0397f/drug-label-0012-of-0014.json.zip
- Source manifest SHA-256
- 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
- Import run
- 20261013T011858Z
- Imported at
- 2026-10-13 02:50:12
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| spl id | a33a31a4-ee79-41c6-ac4d-fef66adfa81e | id | |
| spl set id | e8f79d62-6a62-4099-a282-1d33e9c2ea1b | set_id |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
Adverse Reactions: Note: Included in this listing which follows are a few adverse reactions which may not have been reported with this specific drug. However, pharmacological similarities among the xanthine drugs require that each of the reaction be considered when Dyphylline is administered. The most consistent adverse reactions are: nausea, vomiting, and epigastric pain, generally preceded by headache, hematemesis, diarrhea. Central nervous system stimulation: irritability, restlessness, insomnia, reflex hyperexcitability, muscle twitching, clonic and tonic generalized convulsions, agitation. Cardiovascular: palpitation, tachycardia, extra systoles, flushing, marked hypotension, and circulatory failure. Respiratory: tachypnea, respiratory arrest. Renal: albuminaria, increased excretion of renal tubule and red blood cells. Others: fever and dehydration.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.